The potential of Onconase as an early first-line preventative treatment for mesothelioma is an exciting development that we plan to investigate through clinical trials,” said Dr. Carbone.
Michelle Carbone, M.D., Ph.D. is a mesothelioma researcher whose opinion holds a lot of water throu...




This article is courtesy of Mesothelioma Reporter

Add to Google

Trackback address for this post

Trackback URL (right click and copy shortcut/link location)

No feedback yet

Leave a comment


Your email address will not be revealed on this site.

Your URL will be displayed.
(Line breaks become <br />)
(Name, email & website)
(Allow users to contact you through a message form (your email will not be revealed.)